C

Congruence Therapeutics

24 employees

Congruence Therapeutics operates as a biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
protein misfolding
Medical
machine learning
computational chemistry

Date founded

2021

Funding rounds raised

Total raised

$50M

from 6 investors over 6 rounds

C

Congruence Therapeutics raised $15M on March 6, 2023

Investors: OrbiMed Advisors and Amplitude Ventures

C

Congruence Therapeutics raised $50M on February 8, 2022

Investors: Amplitude Ventures, OrbiMed Advisors, Driehaus Capital Management LLC and Lumira Ventures

FAQ